-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Story /By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
-
Featured News /
From January 21-24 2020, Novartis attended the World Economic Forum Annual Meeting in Davos, Switzerland.
-
Story /Novartis is investing in a novel type of medicine to reduce the risk of heart disease.
-
Story /Novartis investigators find genetic explanations for why some young patients relapse.
-
Story /Combination of two compounds shows promise in the lab
-
Story /Novartis researchers are working to extend the life of organ transplants
-
Story /Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.
-
Story /Molecular glues are a new type of medicine inspired by nature’s matchmakers.
-
Story /In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.